On February 18, 2025, Hangzhou Medoxygen Technology Co., Ltd. (MEDOX) officially became a member of the Global Clinical Engineering Alliance (GCEA), marking international recognition of its technical capabilities and contributions in medical gas engineering for clinical engineering field.  

As a high-tech enterprise, also a specialized and sophisticated enterprise dedicated to innovation in medical gas engineering, MEDOX has consistently focused on integrating medical gas technology and facility with clinical engineering. After rigorous review, MEDOX was granted membership under the “Industry-Based Organizations (IBO)” category. In its welcome letter, GCEA highlighted MEDOX’s alignment with the alliance’s mission and vision, emphasizing future collaboration in advancing global technological innovation, academic programs, and cross-border partnerships.  

As a GCEA member, MEDOX will engage in core initiatives such as international credentialing programs, development of academic curricula, and global standards advocacy. These opportunities will further solidify Medox’s leadership in medical gas engineering and facility management and patient outcomes optimization. Additionally, MEDOX can recommend their experts for editorial roles in the “Global Clinical Engineering Journal” and showcase its achievements through GCEA’s “Country Focus” program, fostering knowledge exchange with global leaders.  

“Joining GCEA is a strategic milestone in our global journey,” stated Dr. Jixun Liu, the MEDOX’s founder. “We are committed to collaborating with international partners to drive clinical engineering innovation and build safer, more efficient medical gas systems worldwide.”